Clinical trial

Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT

NCT07768085

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention AI-assisted abdominal CE-CT reporting Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Standard abdominal CE-CT reporting without AI assistance Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-08-17

PhaseNA

Conditions

Hepatocellular Carcinoma (HCC)unresolved

Intrahepatic Cholangiocarcinoma (Icc)unresolved

Hepatic Metastasisunresolved

Hepatic Hemangiomaunresolved

Cystunresolved

Focal Nodular Hyperplasiaverified · MONDO: focal nodular hyperplasia

Interventions

AI-assisted abdominal CE-CT reportingOTHER

Standard abdominal CE-CT reporting without AI assistanceOTHER

Sponsors & collaborators

Shengjing Hospitallead sponsor

Mapped research locations

ShenyangLiaoning, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07768085 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.